Xianwu M. Pang
18 Jinzhou Road
Nanning, 530028, China
Nanning, 530028, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Retraction notice to "Molecular mechanism of regulating tat protein expression of pingganjiedu TCM in the treatment of AIDS based on network pharmacology" [Int. J. Biol. Macromol. 278 (2024) 134599].
Journal: International journal of biological macromolecules
Published: July 29, 2026
Unraveling HIV-1 spread in Southwest China: a phylogenetic and molecular network approach.
Journal: Frontiers in microbiology
Published: December 05, 2025
Longitudinal molecular network analysis in Guangxi: implications for HIV control.
Journal: AIDS (London, England)
Published: October 09, 2025
Epidemiological Trends and CD4+T Cell Recovery in HIV-1 Patients With HCV/HBV Co-Infection: A Retrospective Cohort Study in Southwest China (2003-2024).
Journal: Journal of medical virology
Published: March 18, 2025
HIV molecular transmission networks among students in Guangxi: unraveling the dynamics of student-driven HIV epidemic.
Journal: Emerging microbes & infections
Published: January 27, 2025
Analysis of HIV transmission characteristics and intervention effects in Guangxi based on molecular networks.
Journal: AIDS (London, England)
Published: October 17, 2024
Corrigendum to "Molecular mechanism of regulating tat protein expression of pingganjiedu TCM in the treatment of AIDS based on network pharmacology" [Int. J. Biol. Macromol. 278(Pt 1) (Aug 8, 2024) 134599].
Journal: International journal of biological macromolecules
Published: October 05, 2024
WTAP-mediated m6A modification promotes drug sensitivity by regulating NR3C1 in prostate cancer.
Journal: Science China. Life sciences
Published: August 26, 2024
Molecular mechanism of regulating tat protein expression of pingganjiedu TCM in the treatment of AIDS based on network pharmacology.
Journal: International journal of biological macromolecules
Published: June 25, 2024
Exploring disparities in HIV-1 pretreatment and acquired drug resistance in China from 2003 to 2022.
Exploring disparities in HIV-1 pretreatment and acquired drug resistance in China from 2003 to 2022.
Journal: The Journal of antimicrobial chemotherapy
Published: April 15, 2024
Impact of HIV-1 genetic diversity on disease progression: a prospective cohort study in Guangxi.
Journal: Frontiers in cellular and infection microbiology
Published: April 10, 2024
Last Updated: 09/26/2026